Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation (Q44124730)

30 November 2017

title

Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation (English)

1 reference

30 November 2017

main subject

liver transplantation

1 reference

1 reference

1 reference

Henry Lik-Yuen Chan

1

1 reference

30 November 2017

Albert Ka-Keung Chui

2

1 reference

30 November 2017

Wan-Yee Lau

3

1 reference

30 November 2017

Francis Ka-Leung Chan

4

1 reference

30 November 2017

May-Ling Wong

5

1 reference

30 November 2017

Chi-Hang Tse

6

1 reference

30 November 2017

Araga Ramesha Nitin Rao

7

1 reference

30 November 2017

John Wong

8

1 reference

30 November 2017

Joseph Jao-Yiu Sung

9

1 reference

30 November 2017

publication date

1 October 2002

1 reference

Journal of Medical Virology

30 November 2017

published in

1 reference

30 November 2017

volume

68

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

182-187

1 reference

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

30 November 2017

cites work

1 reference

Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis

21 January 2018

1 reference

High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system

21 January 2018

1 reference

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

21 January 2018

1 reference

Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis

21 January 2018

1 reference

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization

21 January 2018

1 reference

High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation

21 January 2018

1 reference

Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up

21 January 2018

1 reference

Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient

21 January 2018

1 reference

Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.

21 January 2018

1 reference

Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes

21 January 2018

1 reference

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

21 January 2018

1 reference

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection

21 January 2018

1 reference

Liver transplantation and hepatitis B virus infection: the situation seems to be under control, but the virus is still there

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.10185

1 reference

30 November 2017

1 reference